We’re attending the BOPA Conference 2025
03-05 October 2025
ICC Belfast, Northern Ireland
Book a meetingJoin us at the British Oncology Pharmacy Association (BOPA) Conference 2025, where this year’s theme focuses on: “Maximising the potential of the cancer pharmacy team to optimise the care of people living with cancer.”
This important event brings together oncology pharmacy leaders, clinicians and industry experts to share innovation, best practice and collaborative strategies for delivering better outcomes for people living with cancer.
Meet the Sciensus Team at BOPA 2025
Our experts will be on-site at the ICC Belfast and at stand 31 to discuss how we can work with you to achieve better outcomes in oncology.
Achieve more with Sciensus
We can help you:
- Grow your impact – expand access and deepen engagement where infrastructure exists
- Explore new possibilities – leverage our expertise in service innovation and proof-of-concept delivery across oncology
- Strengthen partnerships – collaborate with a trusted partner committed to driving patient-centred outcomes
Empowering oncology innovation
At Sciensus, we partner with healthcare teams and biopharma to deliver more personalised, accessible and effective cancer care. From in-home clinical services to data-driven insights, we support oncology pharmacy teams in improving patient experience, safety and treatment outcomes.
With over 30 years of experience and a deep understanding of cancer therapies, we’re helping transform care pathways for thousands of patients across Europe.
Visit us at stand 31 to learn more about how we can support you and your teams.
Let’s connect at BOPA 2025
We’d love to meet you in Belfast. Book a meeting with our team ahead of the conference – or visit us at Stand 31 to discuss how we can work together to maximise the potential of the cancer pharmacy team and deliver better care for people living with cancer.
Oncology expertise that delivers
With a proven track record in oncology services, Sciensus brings scale, innovation and partnership that makes a difference.
0 +
cancers treated via systemic anti-cancer therapies
0
clinical deliveries annually
0 +
regimens across 125 medicines
0 +
patient interactions across Europe
Get a faster route into Europe
Request a meeting for a focused strategic conversation on your asset, where we’ll explore how you can accelerate access to Europe by using one integrated partner for end-to-end support.